- AU$15.80m
- AU$19.47m
Brief: Imugene Announces Termination Of Supply Agreement With MSD
Australia Stock Exchange release from IMUGENE : PRE_NR Ends: 09:26:22
Australia Stock Exchange release from IMUGENE : Dose Escalation in Phase 1 Clinical Trial of CHECKvacc
Brief: Imugene Got Western Institutional Review Board Approval To Commence Phase I Clinical Trial Of Oncolytic Virotherapy Candidate, Vaxinia
Australia's Imugene jumps on ethics approval to study cancer treatment
Australia Stock Exchange release from IMUGENE : Clinical Trial of New Cancer Oncolytic Virotherapy Vaxinia
Australia Stock Exchange release from IMUGENE : PRE_NR Ends: 10:05:35
Brief: Imugene Ltd Announces New Clinical Trial Collaboration And Supply Agreement With MSD
Australia Stock Exchange release from IMUGENE : Investor webinar Imugene & Merck collaboration
Australia Stock Exchange release from IMUGENE : Imugene HER-Vaxx Clinical Trial Collaboration with Merck
Australia Stock Exchange release from IMUGENE : PRE_NR Ends: 08:39:10
Australia Stock Exchange release from IMUGENE : Application for quotation of securities - IMU
Australia Stock Exchange release from IMUGENE : PRE_NR Ends: 10:18:46
Australia Stock Exchange release from IMUGENE : Half Yearly Report and Accounts
Australia Stock Exchange release from IMUGENE : Science Series CHECKvacc
Australia Stock Exchange release from IMUGENE : Notice Under Section 708A
Australia Stock Exchange release from IMUGENE : Application for quotation of securities - IMU
Australia Stock Exchange release from IMUGENE : Change of Director's Interest Notice - JE
Australia Stock Exchange release from IMUGENE : Notification regarding unquoted securities - IMU